How does doubling lipitor affect cholesterol levels and safety?

How does doubling Lipitor affect cholesterol levels?
Doubling the dose of Lipitor (atorvastatin) typically lowers LDL cholesterol by an additional 6-7% beyond the reduction achieved at the starting dose. This follows the rule that each doubling of a statin dose produces only modest extra LDL lowering rather than a proportional drop.
Why does the extra reduction stay small?
Statins reach most of their LDL-lowering effect at moderate doses. Higher doses mainly block a bit more of the liver enzyme HMG-CoA reductase, but the body compensates, limiting further gains.
What safety issues arise when the dose is doubled?
Higher doses increase the chance of muscle pain, weakness, or rare cases of rhabdomyolysis. Liver enzyme elevations also occur more often, so doctors usually check liver function and watch for drug interactions that raise atorvastatin levels.
Can other approaches match or beat the benefit of doubling?
Adding ezetimibe or switching to a more potent statin such as rosuvastatin often lowers LDL further without the same jump in side-effect risk. Lifestyle changes and newer agents like PCSK9 inhibitors provide additional options when more reduction is needed.
When does the patent for Lipitor expire?
The main U.S. patent for atorvastatin expired in 2011, allowing generic versions to enter the market and reduce cost.